サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1801237

人工椎間板の市場規模、シェア、動向、予測：椎間板タイプ、材料タイプ、エンドユーザー、地域別、2025～2033年

Artificial Disc Market Size, Share, Trends and Forecast by Disc Type, Material Type, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
人工椎間板の市場規模、シェア、動向、予測：椎間板タイプ、材料タイプ、エンドユーザー、地域別、2025～2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工椎間板の世界市場規模は2024年に36億3,000万米ドルとなりました。今後、IMARC Groupは、2033年には138億4,000万米ドルに達し、2025～2033年にかけて15.24%のCAGRを示すと予測しています。北米が市場を独占し、2024年には56.2%という大きな市場シェアを占めます。人口の高齢化、ヘルスケアの高度化、有利な償還、医療機器の存在感の強さなどが、人工椎間板市場シェアの要因となっています。

同市場は、特に高齢化社会における椎間板変性症や関連脊椎疾患の有病率の増加が主要因となっています。患者は脊椎固定術に代わる治療法を求めるようになっており、椎間板全置換術のような運動温存手術が好まれています。改良された生体材料、解剖学的設計、多段階適合性などのインプラント技術の進歩により、臨床転帰と患者の満足度が大幅に向上しています。耐久性、再置換率の低さ、脊柱の可動性の維持を示す強力な長期的データが、さらに採用を後押ししています。手術手技の向上と臨床エビデンスの増加により、外科医は自信を持ってこれらの器具を推奨しています。また、いくつかの地域では保険償還の枠組みが優遇されており、ヘルスケアへの投資が増加していることも、人工椎間板市場の成長に寄与しています。さらに、侵襲性の低い新しい脊椎治療に対する患者の意識は高まり続けており、慢性腰痛や脊椎の不安定性に対する長期的な解決策としての人工椎間板の需要を後押ししています。

米国では、変性椎間板疾患の治療を目的とした核置換デバイスの臨床研究活動が活発化しています。新たな臨床検査は、椎間板の機能を維持する低侵襲性の選択肢に焦点を当てており、従来型椎間板全置換術にとどまらず人工椎間板技術を拡大し、より的を絞った治療アプローチを提供することへの継続的な関心を反映しています。例えば、2025年3月、Spinal Stabilization Technologies, LLCは、PerQdisc Nucleus Replacement Device（NRD）のIDE（Investigational Device Exemption）臨床検査において、米国で最初の個人の登録を発表しました。この開発により、変性椎間板変性症（DDD）患者に対するPerQdisc人工椎間板デバイスを評価するSSTの米国ベース臨床検査が正式に開始されたことになります。

人工椎間板の市場動向

脊柱の動きを保持するソリューションへの嗜好の高まり

世界人口の高齢化は、脊椎疾患、特に変性椎間板障害の着実な増加に寄与しています。可動性と生活の質を維持する解決策を求める人が増える中、人工椎間板による置換術は、従来型固定術よりも支持を集めています。人工椎間板市場動向の主要特徴は、回復の早さ、入院期間の短縮、合併症発生率の低下に対する需要に後押しされ、侵襲性の低い手術手技へのシフトが進んでいることです。このような手術は、手術器具の改良やヘルスケアプロバイダの専門知識の向上により、より利用しやすくなっています。患者の高齢化と低侵襲手術法の進歩が相まって、頸椎と腰椎の両用途における人工椎間板の魅力と使用は着実に高まっています。世界保健機関（WHO）によると、60歳以上の高齢者の数は、2050年までに世界総人口の22％を占めると予想されています。また、IMARC Groupのレポートによると、世界の低侵襲手術市場は2024年に561億米ドルに達し、2025～2033年にかけて5.72％のCAGRで成長すると予測されています。

腰椎椎間板インプラントの信頼性を高める臨床的検証

最近の長期にわたる臨床的知見により、特に過去の手術を含む複雑な症例において、腰椎人工椎間板人工椎間板置換術に対する信頼が高まっています。長期の追跡調査を行った大規模な研究により、広く使用されている腰椎椎間板システムの強い安全性と耐久性の結果が示されました。患者は1レベルでも2レベルでも一貫して良好な結果を示し、長期にわたって再置換術を必要とする症例はほとんどなかりました。これらの結果は、変性椎間板疾患の治療における信頼できる選択肢としての人工椎間板の役割を立証するものであり、脊椎治療における人工椎間板の使用の拡大を支持するものです。人工椎間板市場の展望は、外科医やヘルスケアシステムが、このような実績のある人工椎間板への依存度を高めていく可能性が高く、長期的なデータによって、人工椎間板の動きを維持し、二次的な介入の必要性を減らす有効性が引き続き支持されているため、依然として明るいです。例えば、2024年12月にJournal of Bone & Joint Surgery誌のオンライン版で発表された画期的な研究では、Centinel Spineのprodisc L腰椎人工椎間板の長期的な成功が確認されました。1,187人の患者を対象とし、7～21年間の追跡調査を行ったこの研究では、再置換率は0.67％と低く、1レベルと2レベルの症例（過去の手術歴も含む）において、良好な転帰が得られたと報告しています。これらの所見は、変性椎間板疾患の治療におけるプロ椎間板Lの耐久性と安全性を補強するものです。

越境脊椎手術の役割の拡大

医療旅行は、患者が自国以外の場所で、より低費用で質の高い治療を求めるため、人工椎間板産業により強い影響を与えるようになってきています。先進的脊椎治療を受けるために渡航する人が増えており、人工椎間板の市場予測は、特に熟練した外科医、近代的な施設、費用対効果の高い治療オプションを提供する地域における国際的な需要の高まりを反映しています。越境治療の魅力の高まりは、手術基準の向上、国際的に認定された病院、人工椎間板交換のような先進的治療へのアクセスによって支えられています。慢性的な背中の痛みに悩む人々は、熟練した外科医が競合価格で脊柱の動きを温存する手術を行う、海外での選択肢を模索するようになっています。このような動きは選択的手術に限ったことではなく、複雑な脊椎治療をどこでどのように行うかということにも影響を及ぼしています。より多くの国が専門的な治療のハブとして位置づけられるにつれ、人工椎間板技術は、従来型市場を超えた新たな患者層にも認知され、採用されるようになってきています。例えば、IMARC Groupによると、世界の医療ツーリズム市場は2024年に1,445億米ドルに達し、2025～2033年にかけて19.08%のCAGRで成長すると予測されています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の人工椎間板市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：椎間板タイプ別

  • 頸部人工椎間板
  • 腰椎人工椎間板

第7章 市場内訳：材料別

  • メタル・オン・ポリマー
  • メタル・オン・メタル

第8章 市場内訳：エンドユーザー別

  • 病院とクリニック
  • 外来手術センター
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • B. Braun Melsungen Aktiengesellschaft（B. Braun Holding GmbH & Co. KG）
    • Depuy Synthes Inc.（Johnson & Johnson）
    • Globus Medical Inc.
    • Medtronic Plc
    • Nuvasive Inc.
    • Orthofix Medical Inc.
    • Paradigm Spine LLC（RTI Surgical Holdings Inc.）
    • Smith & Nephew plc
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.
図表

List of Figures

  • Figure 1: Global: Artificial Disc Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Disc Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Disc Market: Breakup by Disc Type (in %), 2024
  • Figure 4: Global: Artificial Disc Market: Breakup by Material Type (in %), 2024
  • Figure 5: Global: Artificial Disc Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Artificial Disc Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Disc Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Artificial Disc (Cervical Artificial Disc) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Disc (Cervical Artificial Disc) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Disc (Lumbar Artificial Disc) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Disc (Lumbar Artificial Disc) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Disc (Metal on Polymer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Disc (Metal on Polymer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Disc (Metal on Metal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Disc (Metal on Metal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Disc (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Disc (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Disc (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Disc (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Disc (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Disc (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia Pacific: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia Pacific: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Artificial Disc Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Artificial Disc Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: Artificial Disc Industry: SWOT Analysis
  • Figure 71: Global: Artificial Disc Industry: Value Chain Analysis
  • Figure 72: Global: Artificial Disc Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Disc Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Disc Market Forecast: Breakup by Disc Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Disc Market Forecast: Breakup by Material Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Disc Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Artificial Disc Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Disc Market Structure
  • Table 7: Global: Artificial Disc Market: Key Players
目次
Product Code: SR112025A2449

The global artificial disc market size was valued at USD 3.63 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 13.84 Billion by 2033, exhibiting a CAGR of 15.24% during 2025-2033. North America dominated the market, holding a significant market share of 56.2% in 2024. Aging population, advanced healthcare, favorable reimbursement, and strong medical device presence are some of the factors contributing to the artificial disc market share.

The market is primarily driven by the growing prevalence of degenerative disc disease and related spinal disorders, especially among aging populations. Patients increasingly seek alternatives to spinal fusion, favoring motion-preserving procedures like total disc replacement. Advances in implant technology, such as improved biomaterials, anatomical designs, and multi-level compatibility, have significantly enhanced clinical outcomes and patient satisfaction. Strong long-term data demonstrating durability, low revision rates, and preservation of spinal mobility further support adoption. Surgeons are more confident in recommending these devices due to improved surgical techniques and growing clinical evidence. Favorable reimbursement frameworks in several regions and increasing healthcare investments also contribute to the artificial disc market growth. Additionally, patient awareness about newer, less invasive spinal treatments continues to rise, helping fuel demand for artificial discs as a long-term solution to chronic back pain and spinal instability.

Clinical research activity in the US is increasing for nucleus replacement devices aimed at treating degenerative disc conditions. New trials are focusing on minimally invasive options that preserve disc function, reflecting continued interest in expanding artificial disc technologies beyond traditional total disc replacements and offering more targeted treatment approaches. For instance, in March 2025, Spinal Stabilization Technologies, LLC announced the enrollment of the first U.S. individual in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD). This development marks the official commencement of SST's U.S.-based trial to assess its PerQdisc artificial disc device for patients with degenerative disc degeneration (DDD).

Artificial Disc Market Trends:

Growing Preference for Motion-Preserving Spine Solutions

An aging global population is contributing to a steady rise in spinal conditions, particularly degenerative disc disorders. As more individuals seek solutions that maintain mobility and quality of life, artificial disc replacement is gaining traction over traditional fusion surgeries. A key feature of artificial disc market trends is the growing shift toward less invasive surgical techniques, driven by demand for faster recovery, reduced hospital stays, and lower complication rates. These procedures are becoming more accessible due to improvements in surgical tools and growing expertise among healthcare providers. The combination of an older patient base and advancements in minimally invasive methods is steadily increasing the appeal and use of artificial discs in both cervical and lumbar applications. According to the World Health Organization, the number of geriatric individuals aged 60 years and over is expected to account for 22% of the total global population by 2050. The global minimally invasive surgery market also reached USD 56.1 Billion in 2024 and is forecasted to grow at a CAGR of 5.72% during 2025-2033, as per a report by the IMARC Group.

Clinical Validation Strengthening Confidence in Lumbar Disc Implants

Recent long-term clinical findings have reinforced confidence in lumbar artificial disc replacements, especially in complex cases involving prior surgeries. A major study with extended follow-up demonstrated strong safety and durability outcomes for a widely used lumbar disc system. Patients showed consistently positive results in both single- and two-level procedures, with very few requiring revisions over time. These results help validate the role of artificial discs as a dependable option for treating degenerative disc disease, supporting their growing use in spine care. The artificial disc market outlook remains positive as surgeons and healthcare systems are likely to rely more on such proven devices, with long-term data continuing to support their effectiveness in preserving motion and reducing the need for secondary interventions. For example, a landmark study published online in December 2024 by the Journal of Bone & Joint Surgery confirmed the long-term success of Centinel Spine's prodisc L lumbar artificial disc. Involving 1,187 patients with 7-21 years of follow-up, the study reported a low revision rate (0.67%) and strong outcomes across 1- and 2-level cases, including prior surgeries. These findings reinforce the durability and safety of prodisc L in treating degenerative disc disease.

Expanding Role of Cross-Border Spine Procedures

Medical travel is becoming a stronger influence on the artificial disc industry, as patients seek high-quality care at lower costs outside their home countries. With more individuals traveling for advanced spine procedures, the artificial disc market forecast reflects growing international demand, especially in regions offering skilled surgeons, modern facilities, and cost-effective treatment options. The growing appeal of cross-border treatment is supported by improved surgical standards, internationally accredited hospitals, and access to advanced procedures like artificial disc replacement. Individuals dealing with chronic back pain are increasingly exploring options abroad where skilled surgeons perform motion-preserving spine surgeries at competitive prices. This movement is not limited to elective procedures; it's also shaping how and where complex spine treatments are delivered. As more countries position themselves as hubs for specialized care, artificial disc technologies are gaining visibility and adoption across new patient populations beyond traditional markets. For instance, the global medical tourism market reached USD 144.5 Billion in 2024 and is projected to grow at a CAGR of 19.08% from 2025-2033, according to the IMARC Group.

Artificial Disc Industry Segmentation:

Analysis by Disc Type:

  • Cervical Artificial Disc
  • Lumbar Artificial Disc

Cervical artificial disc stood as the largest disc type in 2024, holding around 65.9% of the market due to rising demand for less invasive solutions to cervical spine degeneration. These discs are used to replace damaged intervertebral discs in the neck and help preserve natural motion, unlike spinal fusion, which restricts it. Increasing prevalence of cervical degenerative disc disease among the aging population and a growing preference for motion-preserving surgeries are pushing hospitals and surgeons to opt for artificial cervical discs. Technological advancements have improved implant materials and surgical techniques, reducing complication rates and speeding up recovery. Reimbursement support in developed countries and favorable long-term clinical outcomes are encouraging wider adoption. This segment is also gaining momentum due to expanding regulatory approvals and its proven ability to reduce adjacent segment degeneration compared to traditional methods.

Analysis by Material Type:

  • Metal on Polymer
  • Metal on Metal

Metal on polymer led the market with around 64.2% of market share in 2024, owing to its favorable clinical performance, durability, and cost-effectiveness. These implants typically use a metal endplate and a polymer core, offering smoother articulation and reducing wear compared to metal-on-metal designs. Surgeons favor this configuration because it mimics natural disc movement while minimizing the risk of metal ion release, a concern with some older implant types. Patients benefit from improved mobility and lower complication rates. Manufacturers continue refining polymer materials to enhance strength and longevity, making them more suitable for long-term implantation. The segment's popularity is rising in both cervical and lumbar applications, especially in regions where price sensitivity matters. Regulatory approvals and clinical success stories are further boosting adoption, making metal-on-polymer a preferred option in artificial disc replacement procedures.

Analysis by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Hospitals and clinics led the market with around 70.8% of market share in 2024 because of increased patient volume, better surgical infrastructure, and access to advanced spinal procedures. These facilities are often the first choice for patients seeking treatment for degenerative disc disorders, especially as awareness grows about alternatives to spinal fusion. Hospitals and large clinics are equipped with skilled orthopedic and neurosurgeons, imaging systems, and post-operative care units that support complex procedures like artificial disc replacement. They also benefit from direct partnerships with device manufacturers, ensuring the timely availability of approved implants. With rising healthcare spending and government investments in surgical capabilities, particularly in urban areas, more hospitals are incorporating motion-preserving spinal surgeries into their standard offerings. Insurance coverage and reimbursement support are typically more accessible through hospital networks, making them central to the rising demand for artificial disc implants.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 56.2%. The region has a high volume of spinal surgeries, driven by a large aging population prone to degenerative disc disorders. Access to advanced healthcare facilities and skilled surgeons also plays a major role. Regulatory support and quicker approvals from authorities like the FDA have helped bring new technologies to market faster. Insurance coverage and favorable reimbursement policies make artificial disc replacement a viable option for more patients. Additionally, the presence of key medical device manufacturers in the U.S. ensures faster product availability and continued innovation. Public awareness of spinal health and early treatment has also improved adoption. Together, these factors have established North America as the leading region in the artificial disc market, with strong growth potential going forward.

Key Regional Takeaways:

United States Artificial Disc Market Analysis

In 2024, the United States accounted for 87.7% of the market share in North America. The growth of the US artificial disc market is primarily driven by the increasing prevalence of spine-related disorders, such as degenerative disc disease and other spinal disorders, which require advanced treatment solutions. According to the National Spine Health Foundation, evidence of disc degeneration is found in approximately 90% of individuals aged 60 years and older. The rising geriatric population is a significant factor, as age-related spinal issues are more common among older adults, creating a greater demand for artificial disc replacement (ADR) procedures. Additionally, the growing preference for minimally invasive procedures over traditional spinal fusion surgeries is contributing substantially to market growth, as ADR offers benefits such as faster recovery times, less pain, and improved range of motion. The rise in healthcare expenditure and investment in the healthcare sector, along with the availability of advanced surgical techniques, is also supporting the market. According to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditures in the United States increased by 7.5% in 2023, reaching USD 4.9 Trillion or USD 14,570 per person and accounting for 17.6% of the GDP of the country. Other than this, reimbursement policies for spine surgeries and ADR procedures are becoming more favorable, which boosts the accessibility of artificial disc surgeries, further driving market growth.

Asia Pacific Artificial Disc Market Analysis

The Asia Pacific artificial disc market is expanding due to a rising incidence of spinal injuries, particularly related to lifestyle changes, high mobility in urban populations, and sports-related trauma, which has led to greater demand for artificial disc replacement (ADR) procedures. For instance, the incidence of spinal cord injuries (SCI) in China reached 99,363 cases in 2021, marking an increase of 43.27% since 1990. The prevalence of SCI reached 2,766,277 cases, recording a growth of 63.27% since 1990. Additionally, the region's growing focus on healthcare modernization and the adoption of advanced medical technologies is making ADR more accessible. Increased investments in healthcare infrastructure and the establishment of specialized spinal surgery centers across emerging markets are contributing substantially to industry expansion. For instance, in August 2023, the specialized Institute of Brain & Spine was established at Radial Road's Kauvery Hospital in India. The Institute provides exceptional facilities, cutting-edge technologies, and a skilled group of specialized physicians that achieve the intended clinical results, enhancing the quality of life for each and every one of its patients.

Europe Artificial Disc Market Analysis

The growth of the Europe artificial disc market is largely fueled by the rising demand for advanced spinal treatments. A notable growth-inducing factor is the increasing incidence of degenerative disc diseases, herniated discs, and spinal disorders, particularly among the geriatric population, which is more susceptible to such conditions. For instance, over 50% of the average population suffers from a non-symptomatic herniated disc. Moreover, in European nations, the percentage of hospital discharges connected to spine disorders ranged from 0.8% to 4.3% of all hospital discharges and from 14.2% to 45.6% of all discharges related to musculoskeletal disorders in 2019, according to a study by the National Institutes of Health. Furthermore, in Europe, intervertebral disc problems alone were responsible for 4.9% to 21.1% of all hospital discharges resulting from musculoskeletal disorders. Additionally, the growing preference for patient-centric treatment options, focused on enhancing quality of life and long-term mobility, is significantly propelling the widespread adoption of ADR. Collaborative research and development (R&D) between European medical institutions and manufacturers have also led to more refined, patient-friendly products, further encouraging the adoption of ADR. The expansion of clinical evidence supporting the long-term benefits of ADR, along with the endorsement of professional medical societies, is further fostering market confidence and adoption.

Latin America Artificial Disc Market Analysis

The Latin America artificial disc market is significantly influenced by the growing incidence of spinal conditions. For instance, 19% of individuals in Brazil aged 18 years and above reported suffering from chronic spinal pain. Moreover, the demand for minimally invasive surgeries is rising as patients seek less invasive treatments with quicker recovery times, making artificial disc replacement (ADR) an attractive alternative to traditional spinal fusion surgeries. Improvements in healthcare infrastructure and access to advanced medical technologies in countries such as Brazil and Mexico are also making ADR procedures more available. Besides this, increasing awareness about the benefits of ADR, along with favorable reimbursement policies and rising disposable incomes, are substantially driving market growth, allowing more patients to afford advanced spinal care solutions.

Middle East and Africa Artificial Disc Market Analysis

The Middle East and Africa artificial disc market is experiencing robust growth, driven by the increasing demand for advanced spinal treatments due to a higher incidence of lifestyle-related spinal issues and injuries. Moreover, the region's expanding healthcare infrastructure is making ADR procedures more accessible. Growing healthcare investments and expenditures, particularly in countries such as the UAE and Saudi Arabia, are further contributing to better availability of specialized treatments. For instance, the Government of Saudi Arabia allocated SR 86,253,063 to the Ministry of Health for FY25, equating to 7% of the state budget. Besides this, increased awareness and education about ADR benefits, along with favorable healthcare policies and insurance coverage, are also driving industry expansion in the region.

Competitive Landscape:

The artificial disc market is experiencing notable growth, driven by technological advancements and strategic initiatives. Recent developments include the introduction of innovative products like NGMedical's MOVE-C cervical disc and Orthofix's M6-C, which have demonstrated superior clinical outcomes. Companies such as NuVasive and Centinel Spine are actively engaging in partnerships and acquisitions to enhance their product offerings and market presence. Research and development efforts are focused on new biomaterials and 3D printing techniques to create customized implants, improving patient outcomes. Government initiatives, including increased funding and supportive reimbursement policies, are facilitating the adoption of artificial disc procedures. Among these activities, product launches and strategic collaborations are currently the most prevalent practices, reflecting the industry's emphasis on innovation and market expansion.

The report provides a comprehensive analysis of the competitive landscape in the artificial disc market with detailed profiles of all major companies, including:

  • B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)
  • Depuy Synthes Inc. (Johnson & Johnson)
  • Globus Medical Inc.
  • Medtronic plc
  • Nuvasive Inc.
  • Orthofix Medical Inc.
  • Paradigm Spine LLC (RTI Surgical Holdings Inc.)
  • Smith & Nephew Plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.

Key Questions Answered in This Report

  • 1.How big is the artificial disc market?
  • 2.What is the future outlook of artificial disc market?
  • 3.What are the key factors driving the global artificial disc market?
  • 4.Which region accounts for the largest artificial disc market share?
  • 5.Which are the leading companies in the global artificial disc market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Disc Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disc Type

  • 6.1 Cervical Artificial Disc
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lumbar Artificial Disc
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Material Type

  • 7.1 Metal on Polymer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Metal on Metal
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Depuy Synthes Inc. (Johnson & Johnson)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Globus Medical Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Medtronic Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Nuvasive Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Orthofix Medical Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Paradigm Spine LLC (RTI Surgical Holdings Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Smith & Nephew plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zimmer Biomet Holdings Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis